Home›Companies›Biotech & Pharma›Clear Labs

Clear Labs, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 30, 2024·Suggest an edit

About Clear Labs

Clear Labs is a private company based in San Carlos, California. It has reported $135,830,840 raised in five offerings on Form D since January 2014.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 12, 2024Dec 30, 2024$29,062,615of $50.0M target33$880KEquityRule 506(b)Form D ↗
May 13, 2021May 28, 2021$59,999,933of $70.0M target30$1.9MEquity, Offering of Series C Preferred Stock ("Series C") and the underlying shares of Common Stock issuable upon conversion of Series C.Rule 506(b)Form D ↗
Oct 24, 2018Oct 30, 2018amended May 19, 2020$39,538,382of $40.9M target28$1.4MEquity, Offering of Series B-1 Preferred Stock ("Series B-1") and the underlying shares of Common Stock issuable upon conversion of Series B-1.Rule 506(b)Form D/A ↗1 earlier filing
Aug 31, 2015Sep 15, 2015$6,179,911of $6.5M target21$294KEquity, Offering of Series A-2 Preferred Stock ("Series A-2) and the underling shares of Common Stock issuable upon conversion of Series A-2.Rule 506(b)Form D ↗
Oct 2, 2013Jan 3, 2014$1,049,999of $1.5M target6$174KEquity, Offering of Series A Preferred Stock ("Series A") and the underlying shares of Common Stock issuable upon conversion of Series A.Rule 506(b)Form D ↗
Total, five offerings$135,830,840

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Clear Labs's Form D filed Dec 30, 2024.

GY
Greg Yap
Director
Gaurav Garg
Gaurav Garg
Director
Also a founding partner, wing venture capital and director at Obsidian Security.
Mostafa Ronaghi
Mostafa Ronaghi
Director
Also a director at 1health.io Inc.. and Tachin.AI and a cofounder, executive board member at Cellanome.
SA
Sasan Amini
Executive officer and director
Ming Fang
Ming Fang
Director
Also a managing director, redmile group at Abcuro and a director at GRO Biosciences.
RK
Ramin Khaksar
Executive officer
EF
Edward Fan
Chief Financial Officer

Earlier filings also listed Michael Taylor (director, last listed May 2021), Michael Robach (director, last listed May 2021), Jeff Field (executive officer, last listed May 2021), Brian Hogan (executive officer, last listed May 2021), Nicolas Roelofs (director, last listed Sep 2015), Kazutaka Ohno (executive officer, last listed Sep 2015), Charlie Piper (director, last listed Sep 2015) and Richard Murdock (director, last listed Jan 2014).

Sources

  1. SECClear Labs, Inc. Form D, filed Oct 30, 2018
  2. SECClear Labs, Inc. filing history